[PDF][PDF] Supplemental File S1–Detailed description of computational model

QWAD Arnheim, SD Finley - rs.figshare.com
The model is comprised of three compartments representing the whole mouse (Figure 1):
normal tissue, blood, and tumor tissue. We include human VEGF isoforms (VEGF121 and …

[HTML][HTML] Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice

SD Finley, M Dhar, AS Popel - Frontiers in oncology, 2013 - frontiersin.org
Angiogenesis, the formation of new blood vessels from existing vasculature, is important in
tumor growth and metastasis. A key regulator of angiogenesis is vascular endothelial growth …

[HTML][HTML] A two-compartment model of VEGF distribution in the mouse

P Yen, SD Finley, MO Engel-Stefanini, AS Popel - PloS one, 2011 - journals.plos.org
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis–the growth of
new microvessels from existing microvasculature. Angiogenesis is a complex process …

[HTML][HTML] A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap

FTH Wu, MO Stefanini, F Mac Gabhann, AS Popel - PloS one, 2009 - journals.plos.org
Vascular endothelial growth factor (VEGF), through its activation of cell surface receptor
tyrosine kinases including VEGFR1 and VEGFR2, is a vital regulator of stimulatory and …

[HTML][HTML] The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling

MO Stefanini, FTH Wu, F Mac Gabhann… - PLoS computational …, 2009 - journals.plos.org
Vascular endothelial growth factor (VEGF) is a potent cytokine that binds to specific
receptors on the endothelial cells lining blood vessels. The signaling cascade triggered …

[HTML][HTML] A compartment model of VEGF distribution in blood, healthy and diseased tissues

MO Stefanini, FTH Wu, F Mac Gabhann, AS Popel - BMC systems biology, 2008 - Springer
Background Angiogenesis is a process by which new capillaries are formed from pre-
existing blood vessels in physiological (eg, exercise, wound healing) or pathological (eg …

[HTML][HTML] Trafficking dynamics of VEGFR1, VEGFR2, and NRP1 in human endothelial cells

S Sarabipour, K Kinghorn, KM Quigley… - PLOS Computational …, 2024 - journals.plos.org
The vascular endothelial growth factor (VEGF) family of cytokines are key drivers of blood
vessel growth and remodeling. These ligands act via multiple VEGF receptors (VEGFR) and …

[HTML][HTML] Stacey Finley

A Popel - J Natl Cancer Inst - bioseek.eu
BACKGROUND Vascular endothelial growth factor (VEGF) is known to be a potent promoter
of angiogenesis under both physiological and pathological conditions. Given its role in …

Simulating therapeutics using multiscale models of the VEGF receptor system in cancer

FM Gabhann, MO Stefanini, AS Popel - Modeling tumor vasculature …, 2012 - Springer
Abstract In recent years, Judah Folkman's vision of anticancer therapeutics based on
inhibiting angiogenesis pathways has begun to be realized. In particular, antibodies …

Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle

FM Gabhann, AS Popel - American Journal of Physiology …, 2007 - journals.physiology.org
The vascular endothelial growth factor (VEGF) family of cytokines is involved in the
maintenance of existing adult blood vessels as well as in angiogenesis, the sprouting of new …